Source: Annual Congress 2002 - Lung Physiology: clinical
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Guven, N. Koksal, E. Caglayan (Kahramanmaras, Turkey). Comparison of the echocardiographic and pulmonary function test findings in treated and untreated hypertensive patients. Eur Respir J 2002; 20: Suppl. 38, 1883

Member's Comments

No comment yet.

Related content which might interest you: Assessment of pulmonary perfusion by MR in patients suffering from pulmonary arterial hypertension (PAH) in comparison to healthy volunteers Source: Eur Respir J 2006; 28: Suppl. 50, 424s Year: 2006 Prognostic significance of right ventricular dysfunction detected by CT/Echocardiography and biomarkers in normotensive patients with pulmonary embolism Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Comparison of pulmonary function in diabetic patients with and without retinopathy and comparing to control group Source: Annual Congress 2009 - Respiratory physiology Year: 2009 Evaluation of the relationship between laboratory parameters and pulmonary function tests in COVID-19 patients Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Echocardiographic measures of right ventricular function poorly correlate with changes in contractility and coupling in treatment naïve patients with pulmonary artery hypertension before and after therapy. Source: International Congress 2017 – Cardiac function assessment in pulmonary hypertension Year: 2017 Haemodynamic correlation and prognostic value of ventricular mass index (VMI) in non-surgically treated chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Correlation of spirometric value to 2D ECHO parameters for diagnosis of pulmonary hypertension in COPD Source: International Congress 2018 – Functional assessment of COPD Year: 2018 Sitaxsentan for pulmonary arterial hypertension (PAH) patients with clinical deterioration or significantly abnormal liver function test on bosentan Source: Eur Respir J 2005; 26: Suppl. 49, 563s Year: 2005 Baseline profile of patients initiating sitaxentan for pulmonary arterial hypertension (PAH): preliminary results from thelin outcomes for patients surveillance (TOPS) Source: Annual Congress 2008 - Pulmonary hypertension II Year: 2008 Ergospirometry findings in patients with scleroderma in relation to concurrent pulmonary hypertension Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases Year: 2010 Comparison of the epidemiological radio-clinical and evolutive profile of pulmonary tuberculosis in diabetic patients and non diabetic ones Source: Eur Respir J 2006; 28: Suppl. 50, 8s Year: 2006 Echocardiographic findings in male patients with OSA: before and after positive airway pressure Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses Source: Eur Respir J 2013; 42: 1575-1585 Year: 2013 Prevalence of pulmonary hypertension among outpatients with sarcoidosis: An echocardiographic and pulmonary catheterization study Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012 The rehabilitative treatment by Free-aspireÒ can reduce pulmonary hypertension in patients with post- cardiac surgery heart failure. Hemodynamic evaluation of echocardiographic parameters Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010 Early diagnostic evaluation of pulmonary hypertension in severe COPD patients (preliminary results) Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006 Amelioration of right ventricular morphology and systolic function in patients with severe group 3 pulmonary hypertension treated with pulmonary vasodilators Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Long-term lung function follow-up in patients diagnosed and treated for pulmonary tuberculosis Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010 Relationship between exercise tolerance and spirometric data in a group of patients affected by idiopathic dilated cardiomyopathy Source: Eur Respir J 2001; 18: Suppl. 33, 84s Year: 2001 Effects of oral dual ERA therapy on pulmonary function testing and 6MWT in patients with idiopathic pulmonary fibrosis and pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012